New Partners Wenzel Spine and Safe group join Forces during NASS,
National American Spine Society, between October 11 and 14th 2022
- Co-promotion of Wenzel and Safe technologies in
NASS
- Inventory delivered to Wenzel Spine for the first
cases
Eragny-sur-Oise, France, Austin, Texas,
USA, October 11th, 2022, 17h45 CET – Safe (FR0013467123 –
ALSAF), a company specializing in the design,
manufacturing, and marketing of ready-to-use technologies and
services for spinal surgeries, and Wenzel Spine, a medical
technology company focused on providing minimally invasive surgical
and diagnostic solutions for the treatment of spinal disorders,
having recently signed two business agreements, are joining forces
during the North American Spine Society (NASS) meeting in Chicago
between the October 11 and 14th, 2022.
The recent strategic partnership between Wenzel
Spine and Safe group will result in the formation of a new
service-based delivery model to include Safe’s ready-to-use
technologies (minimally invasive pedicle screws and vertebral
augmentation technologies) and Wenzel Spine implants and diagnostic
solutions, offering clinical, cost-effective and streamlined
solutions to surgeons especially unique for surgeons performing
spine procedures in ambulatory surgical centers (ASCs) and
outpatient facilities around the US.
Safe Orthopaedics has already delivered stocking
inventory of SteriSpine PS and SteriSpine VA to Wenzel Spine in
order to start surgeries after the NASS congress.
Smart Scaling
Wenzel Spine and Safe Group are open to meet and
collaborate with orthopedic surgeons and neurosurgeon during NASS
who desire to scale their practices to meet the growing demand for
ASC/Outpatient spine procedures, by implementing a smart scaling
solution that is less resource intensive, but results in
equivalency in value to other more resource intensive solutions.
Empowering surgeons to scale their practices with a comprehensive,
patient-centered, service-based delivery model will be the
synergistic effect of their mutual collaboration.
“Wenzel Spine received our inventory from Safe
Orthopaedics earlier this week and we are ready to begin working
with our partners through the expanded solutions that are
immediately available.,” said William Wilson, Co-Founder and
CEO of Wenzel Spine. “Accelerating our growth in both the acute
care and outpatient fusion market with Safe’s ready-to-use
solutions in conjunction with Wenzel’s products will increase the
value of our service offerings to our clients and most importantly
the patients they are treating.”
Pierre Dumouchel, Chairman and CEO of Safe
Group, adds, “The NASS congress is the perfect event to explain the
benefits of our collaboration with Wenzel Spine. Joining our sales
and our marketing forces, we expect to convince our existing
customers to use our consolidated portfolios of technologies and
services and convince new surgeons acting in ambulatory or
outpatient environment. We expect to accelerate our short-term
sales growth and will continue to analyze mid-term options to
maximize synergies between Wenzel and Safe listened surgeons needs
and ambulatory or outpatient centers projects.
Better Together
Wenzel Spine is focused on providing novel MIS
and diagnostic solutions for the treatment of lumbar and cervical
disorders, featuring the S-LIF using VariLift®-LX and S-ACDF using
VariLift®-C—true MIS stand-alone fusion alternatives as they
require no supplemental fixation such as rods, screws, or plates.
VariLift-LX is the only FDA-cleared posterior stand-alone lumbar
interbody fusion device on the market that requires significantly
less hardware to promote fusion while prioritizing healthy anatomy
preservation. Wenzel Spine technologies are currently only
available in the US.
Wenzel Spine’s solutions have been used by over
300 surgeons in 39 states across the USA. With access to over 2,000
hospitals and ASCs and supported by a strong distribution network,
Wenzel Spine has seen outpatient revenue climb 196% post-COVID.
With a shared vision to bring more unique treatment options to
surgeons and their patients, Wenzel Spine and Safe Orthopaedics
will immediately begin distributing the Safe Orthopaedics
ready-to-use technologies (MIS pedicle screws and vertebral
augmentation technologies) and Wenzel Spine implants throughout the
USA.
Safe group specializes in the design,
manufacturing, and marketing of single-use technologies for spinal
surgeries, part of a minimally invasive approach aimed at reducing
the risks of contamination and infection. The company’s patented
SteriSpineTM kits are CE marked and FDA approved.
Safe Medical, the medical device subcontractor
for orthopaedic surgery of the group, will support the design of
ready-to-use technologies and manufacturing of Wenzel Spine
products. The products will be produced in the CIPI* in
Fleurieux-sur-l’Arbresle offering machining, finishing, and
packaging industrial services. Optimizing the cost of technologies
with Safe Medical and developing ready-to-use instrument sets for
Wenzel Spine’s implants will help to initiate distribution
throughout Europe.
About Safe
GroupSafe Group is a French medical technology group that
brings together Safe Orthopaedics, a pioneer in ready-to-use
technologies for spine pathologies, and Safe Medical (formerly LCI
Medical), a medical device subcontractor for orthopaedic surgery.
The group employs approximately 150 people.
Safe Orthopaedics develops and manufactures kits
combining sterile implants and single-use instruments, available at
any time to the surgeon. These technologies are part of a minimally
invasive approach aimed at reducing the risks of contamination and
infection, in the interest of the patient and with a positive
impact on hospitalization times and costs. Protected by 18 patent
families, SteriSpineTM kits are CE marked and FDA approved. Safe
Orthopaedics is headquartered in the Paris region (95610
Eragny-sur-Oise) and has subsidiaries in the United Kingdom,
Germany, the United States, and the Lyon region
(Fleurieux-sur-l'Arbresle).
For more information:
http://www.safeorthopaedics.com/
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation center
and two production sites in France (Fleurieux-sur-l'Arbresle,
69210) and in Tunisia, offering numerous industrial services:
design, industrialization, machining, finishing and sterile
packaging. Supported by the French stimulus plan in 2020, the
company invests in additive printing and will be operational in
2022 on this new technology.
For more information:
http://www.safemedical.fr/
About Wenzel Spine, Inc.Wenzel
Spine, Inc. is a medical technology and services company focused on
providing minimally invasive solutions for the treatment of spinal
disorders. Headquartered in Austin, TX, Wenzel Spine is focused on
delivering surgical solutions that improve the overall quality of
spine care by simplifying procedures and reducing recovery time.
Wenzel Spine seeks to improve patient quality of life by designing
and producing devices of the highest quality to support our surgeon
clients in the care and treatment of their patients.
For more information about the company and
products, visit www.wenzelspine.com.
Contacts
Wenzel SpineWilliam Wilson
Chief Executive Officer 512-469-6066 info@wenzelspine.com
Safe
Group
François-Henri Reynaud
Chief Financial and Administrative Officer
Tél. : +33 (0)1 34 21 50
00
investors@safeorthopaedics.com
- 20221011_PR- NASS Wenzel Safe
SAFE (EU:ALSAF)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
SAFE (EU:ALSAF)
Historical Stock Chart
Von Jul 2023 bis Jul 2024